Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drug.
about
Long-acting injectable antipsychotics update: lengthening the dosing interval and expanding the diagnostic indications.Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable FormulationsEffect of Aluminum Incorporation into Mesoporous Aluminosilicate Framework on Drug Release Kinetics
P2860
Use of mesoporous cellular foam (MCF) in preparation of polymeric microspheres for long acting injectable release formulations of paliperidone antipsychotic drug.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Use of mesoporous cellular foa ...... liperidone antipsychotic drug.
@en
Use of mesoporous cellular foam
@nl
type
label
Use of mesoporous cellular foa ...... liperidone antipsychotic drug.
@en
Use of mesoporous cellular foam
@nl
prefLabel
Use of mesoporous cellular foa ...... liperidone antipsychotic drug.
@en
Use of mesoporous cellular foam
@nl
P2093
P50
P1476
Use of mesoporous cellular foa ...... liperidone antipsychotic drug.
@en
P2093
Dimitrios N Bikiaris
Maria Nerantzaki
Maria Tseklima
Stavroula Nanaki
P356
10.1016/J.EJPB.2017.03.016
P407
P577
2017-04-04T00:00:00Z